Product Information
LEVONOR-ETH ESTRA 0.09-0.02 MG is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $1.1357 per EA under NDC 68462063729. Its NADAC has been published 594 times since May 20, 2015.
FDA first approved this application on Apr 9, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20; 90 ug/1; ug/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462063729
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ETHINYL ESTRADIOL; LEVONORGESTRELApproval Type
Generic (ANDA)
FDA Application
ANDA202791FDA Approved
4/9/2015
TE Code
AB
On Market Since
4/9/2015
Pharmacological Classes
Price Statistics
The NADAC for LEVONOR-ETH ESTRA 0.09-0.02 MG has been published 594 times since May 20, 2015, and over the history we have for it it has declined 30.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1357 per EA |
|---|---|
| All-time high | $1.7050 (Oct 14, 2015) |
| All-time low | $0.7929 (Nov 20, 2024) |
| 52-week high | $1.2766 |
| 52-week low | $1.1357 |
| Median price | $1.2578 |
| Average price | $1.2774 |
| Largest weekly change | -28.9% (Nov 20, 2024) |
| Weeks tracked | 594 |
| Tracking since | May 20, 2015 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levonorgestrel and Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVONOR-ETH ESTRA 0.09-0.02 MG?
The current National Average Drug Acquisition Cost (NADAC) for LEVONOR-ETH ESTRA 0.09-0.02 MG, manufactured by Glenmark Pharmaceuticals Inc., USA, is $1.1357 per EA (NDC 68462063729), effective Sep 30, 2026.
How has the price of LEVONOR-ETH ESTRA 0.09-0.02 MG changed over time?
Over the history we have for it, the NADAC for LEVONOR-ETH ESTRA 0.09-0.02 MG has declined 30.4%. It has been tracked across 594 weekly CMS publications since May 20, 2015.
What are the highest and lowest recorded NADAC prices for LEVONOR-ETH ESTRA 0.09-0.02 MG?
Since May 20, 2015, the NADAC for LEVONOR-ETH ESTRA 0.09-0.02 MG has ranged from a low of $0.7929 (Nov 20, 2024) to a high of $1.7050 (Oct 14, 2015), with a median of $1.2578 per EA.
Are there cheaper alternatives to LEVONOR-ETH ESTRA 0.09-0.02 MG?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LEVONOR-ETH ESTRA 0.09-0.02 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures LEVONOR-ETH ESTRA 0.09-0.02 MG?
LEVONOR-ETH ESTRA 0.09-0.02 MG (NDC 68462063729) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.